Switch to:
More From Other Websites
Austin drugmaker's stock falters after latest FDA rejection Sep 27 2016
Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection Sep 26 2016
5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy Sep 26 2016
GW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH) & More: Why These Stocks Are Making... Sep 26 2016
For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million Sep 26 2016
Is Pain Therapeutics an Incredible Momentum Stock? 3 Reasons Why PTIE Will Be Tough to Beat Sep 26 2016
Get ready. One of tech’s biggest darlings is in for a bumpy ride Sep 26 2016
Pain Therapeutics receives FDA letter saying NDA for opioid analgesic can't be approved Sep 26 2016
Complete Response Letter for REMOXY® Sep 26 2016
DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER... Sep 26 2016
7:05 am Pain Therapeutics receives a CRL from the FDA on the resubmission of its NDA for REMOXY ER;... Sep 26 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events Sep 26 2016
Complete Response Letter for REMOXY® Sep 26 2016
Will Pain Therapeutics (PTIE) Continue to Surge Higher? Sep 23 2016
Pain Therapeutics downgraded by Gabelli & Co Sep 13 2016
PAIN THERAPEUTICS INC Financials Jul 23 2016
Pain Therapeutics (PTIE) Worth a Look: Stock Gains 7.6% Jul 22 2016
Pain Therapeutics reports 2Q loss Jul 19 2016
Pain Therapeutics reports 2Q loss Jul 19 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition Jul 19 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK